High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.

(HealthDay News) — An analysis of more than 13 million electronic health record (EHR) notes shows potential racial bias in how doctors document patient trustworthiness, according to a study ...

High continuous metabolic syndrome severity score trajectory pattern linked to increased risk for CKD in adjusted analyses.

Overall, 68.9 percent of participants who underwent screening at health stations had uncontrolled cardiovascular risk factors.

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

Stereotactic ablative body radiation therapy (SABR) is actively being explored for patients with renal cell carcinoma (RCC).

Research teams investigated the association between hemoglobin levels and cognitive impairment in patients with chronic kidney disease (CKD) or end-stage (ESKD).

The FDA has approved an expanded indication of the IV formulation of Avtozma to include the treatment of CRS in patients 2 years of age and older.

(HealthDay News) — In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the ...

Improved maximum urinary flow rate and lower International Prostate Symptom Scores seen for adherent versus nonadherent patients.